Press Release Nicox and Glaukos Sign Exclusive NCX 1728 Research and Global Licensing Option AgreementOption entitles Glaukos to exclusive global ...

Press Release Nicox Announces Approval of ZERVIATE in ChinaNicox’s partner, Ocumension Therapeutics, has received approval for ZERVIATE® for ...

knu.ac.kr Recently, the approval of the hydrophilic acrylic intraocular lens (IOL; Akreos AO MI60; Bausch & Lomb, Rochester ... chamber was found and resolved with topical steroid eye-drops. Patients ...

At EyeCon 2024, Analisa Arosemena, MD, discussed the shift away from traditional topical therapies towards more proactive ...

Various conditions can cause glaucoma and require different treatment approaches. Surgery can target this serious eye condition in various ways. In glaucoma, high intraocular (inside the eye) pressure ...

According to Nikkhil K Masurkar, CEO of ENTOD Pharmaceuticals, eye drops utilise pilocarpine, a drug that has been extensively studied and used for decades, primarily in glaucoma treatment.

Current glaucoma treatments focus on the use of topical eye drops, surgery, or laser therapy, however the outcomes are variable, with some patients not responding and/or suffering serious side ...

Press Release Nicox and Glaukos Sign Exclusive NCX 1728 Research and Global Licensing Option Agreement Option entitles Glaukos to exclusive global license agreements on pre-agreed terms including ...

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to ...